Journal of insurance medicine (New York, N.Y.)

Aims & Scope

The Journal of Insurance Medicine is the official journal of the American Academy of Insurance Medicine.

It is a peer-reviewed medical journal published quarterly, now exclusively, online.

It is designed with the insurance company medical director throughout the world in mind.

Many of the articles will also be of interest to actuaries and lay underwriters as well as physicians in clinical practice.

The journal covers all aspects of insurance medicine.

Contents include: original research, editorials, commentaries, reviews, international perspectives, case studies and literature reports.

Focusing on individual diseases, topic areas emphasized include: risk assessment, prognosis, mortality, life expectancy, life table methodology, laboratory testing and claims adjudication related to the medical aspects of insurance.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Random Forest

  Citation: 1252

  Authors: Steven J.

• 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes: A Systematic Review of 157,258 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4)

  Citation: 42

  Authors: Anthony F

• Thyroid Cancer: 20-Year Comparative Mortality and Survival Analysis of Six Thyroid Cancer Histologic Subtypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration (SEER*Stat 8.3.2) A Systematic Review of 145,457 Cases for Diagnosis Years 1993–2013

  Citation: 29

  Authors: Anthony F.

• A Four Marker Digital PCR Toolkit for Detecting Heavy Alcohol Consumption and the Effectiveness of Its Treatment

  Citation: 24

  Authors: Robert, Shelly, Amanda, Kelsey, Emma, Donald W, Steven R. H, Jeffrey D, James A, Meeshanthini

• Long COVID - An Early Perspective

  Citation: 13

  Authors: Timothy

• The Cancer Mortality Risk Project – Cancer Mortality Risks by Anatomic Site: Part 1 – Introductory Overview; Part II – Carcinoma of the Colon: 20-Year Mortality Follow-up Derived from 1973-2013 (NCI) SEER*Stat Survival Database

  Citation: 10

  Authors: Anthony F., Richard B.

• AHRR Methylation is a Significant Predictor of Mortality Risk in Framingham Heart Study

  Citation: 9

  Authors: Robert A, Meeshanthini V, James A, Jeffrey D

• Plasma Cell Myeloma – 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973–2014: (SEER*Stat 8.3.4)

  Citation: 8

  Authors: Anthony F.

• Non-Hodgkin Lymphoma – Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6)

  Citation: 7

  Authors: Anthony F.

• NT-proBNP Predicts All-Cause Mortality in a Population of Insurance Applicants, Follow-up Analysis and Further Observations

  Citation: 6

  Authors: Michael, Valerie, Michael, Robert L.